Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Assessing the Impact of dTMS on Neural Targets Associated With Alcohol Use Disorder

NCT: NCT06949423 · RECRUITING

NCT IDNCT06949423
StatusRECRUITING
Start Date2025-12-17
Completion2030-06-30

Brief Summary

The purpose of this study is to evaluate the efficacy of deep transcranial magnetic stimulation as a treatment for Veterans with Alcohol Use Disorder (AUD) to decrease the exceedingly high rate of relapse associated with this condition.

Frequently Asked Questions

What is Assessing the Impact of dTMS on Neural Targets Associated With Alcohol Use Disorder?

Assessing the Impact of dTMS on Neural Targets Associated With Alcohol Use Disorder is a clinical trial registered under NCT06949423. Current status: RECRUITING.

What is the status of NCT06949423?

The current status of NCT06949423 (Assessing the Impact of dTMS on Neural Targets Associated With Alcohol Use Disorder) is: RECRUITING.

When did Assessing the Impact of dTMS on Neural Targets Associated With Alcohol Use Disorder start?

Assessing the Impact of dTMS on Neural Targets Associated With Alcohol Use Disorder started on 2025-12-17.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑